Bladder Symptoms Provoked by Short, Rapid-Acting Loop Diuretics: A Frequent but Often Overlooked Problem

Area of Science:

• Urology
• Cardiology
• Nephrology

Background:

• Bladder dysfunction, including overactive bladder (OAB), affects approximately 15% of US adults.
• OAB symptoms are 2-3 times more common in patients with congestive heart failure (CHF), hypertension, cardiovascular disease (CVD), or chronic kidney disease (CKD).
• Less than 2% of patients with OAB seek treatment, and fear of incontinence from diuretics can lead to nonadherence.

Purpose of the Study:

• To explore the impact of short, rapid-acting loop diuretics on bladder dysfunction in patients with cardiovascular and renal comorbidities.
• To identify alternative diuretic strategies and medications for managing bladder dysfunction in these high-risk populations.

Main Methods:

• Literature search was conducted to review existing studies and clinical data.
• Analysis of the relationship between diuretic use, bladder function, and common comorbidities.

Main Results:

• Short, rapid-acting loop diuretics can exacerbate OAB symptoms due to the bladder's response to rapid fluid shifts.
• This worsening of bladder dysfunction can lead to medication nonadherence and poorer control of conditions like hypertension.
• Alternative treatments, including thiazides, extended-release loop diuretics, or other classes of medication, may be beneficial.

Conclusions:

• Short-acting loop diuretics frequently worsen bladder dysfunction in patients with CVD, CHF, hypertension, and CKD.
• This exacerbation impairs quality of life and adherence, leading to adverse outcomes.
• Consideration of alternative diuretic formulations or medications is crucial for managing bladder dysfunction in these patients.